1. Individualised treatment of COPD exacerbations using biomarkers.
- Author
-
Sivapalan P, Eklöf J, Bonnesen B, Tønnesen L, Wilcke T, and Jensen JS
- Subjects
- Humans, Adrenal Cortex Hormones therapeutic use, Anti-Bacterial Agents therapeutic use, Biomarkers, Disease Progression, Glucocorticoids therapeutic use, Randomized Controlled Trials as Topic, Pulmonary Disease, Chronic Obstructive drug therapy
- Abstract
This review highlights key aspects of treating chronic obstructive pulmonary disease (COPD) exacerbation, focusing on the optimisation of systemic corticosteroid and antibiotic use through personalised treatment using biomarkers. Eosinophil-guided therapy reduces corticosteroid usage which might reduce side effects, while procalcitonin-guided therapy contributes to reduced antibiotic consumption. These approaches, documented through well-conducted randomized controlled trials, suggest the possibility of enhancing COPD exacerbation management, reducing potential side effects, and addressing concerns related to antibiotic resistance., (Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.)
- Published
- 2024
- Full Text
- View/download PDF